4//SEC Filing
SOLAZYME INC 4
Accession 0001555667-13-000039
CIK 0001311230operating
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 7:59 PM ET
Size
7.1 KB
Accession
0001555667-13-000039
Insider Transaction Report
Form 4
SOLAZYME INCSZYM
Dillon Harrison
DirectorCTO and President
Transactions
- Sale
Common Stock
2013-06-17$11.80/sh−13,500$159,327→ 2,045,484 total - Sale
Common Stock
2013-06-18$11.66/sh−13,500$157,368→ 2,031,984 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $11.94, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.57 to $11.90, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
SOLAZYME INC
CIK 0001311230
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311230
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 7:59 PM ET
- Size
- 7.1 KB